Heba A. Hassan

Design and synthesis of novel quinoline/chalcone/1,2,4-triazole hybrids as potent antiproliferative agent targeting EGFR and BRAFV600E kinases

Aliaa M. Mohassab, Heba A. Hassan, Dalia Abdelhamid et al. · Bioorganic Chemistry · 2020 · 114 citations

Pharmacy, Medicinal Chemistry, Oncology +14

New quinoline/chalcone hybrids as anti-cancer agents: Design, synthesis, and evaluations of cytotoxicity and PI3K inhibitory activity

Samar H. Abbas, Amer Ali Abd El‐Hafeez, Mai E. Shoman et al. · Bioorganic Chemistry · 2018 · 67 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Novel quinoline incorporating 1,2,4-triazole/oxime hybrids: Synthesis, molecular docking, anti-inflammatory, COX inhibition, ulceroginicity and histopathological investigations

Aliaa M. Mohassab, Heba A. Hassan, Mohamed Abdel‐Aziz et al. · Bioorganic Chemistry · 2017 · 63 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Structure-based design, synthesis and antiproliferative action of new quinazoline-4-one/chalcone hybrids as EGFR inhibitors

Mohamed Hisham, Heba A. Hassan, Hesham A. M. Gomaa et al. · Journal of Molecular Structure · 2022 · 50 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Novel 4-(piperazin-1-yl)quinolin-2(1H)-one bearing thiazoles with antiproliferative activity through VEGFR-2-TK inhibition

Abdelfattah Hassan, Mohamed Badr, Heba A. Hassan et al. · Bioorganic & Medicinal Chemistry · 2021 · 39 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12